Insiders Mendus AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:52 2024-04-29 am EDT			5-day change	1st Jan Change
0.474 ^SEK	-0.11%		-3.27%	-9.37%

Apr. 16	Mendus AB Announces Board Changes	CI
Mar. 27	Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML	CI

Mendus AB Announces Board Changes	Apr. 16	CI
Mendus AB Appoints Ted Fjällman as Board Member	Dec. 13	CI
Mendus Announces appointment of Nomination Committee for the 2024 Annual General Meeting	Nov. 17	CI
Mendus AB Appoints Lewis Lanier to Scientific Advisory Board	23-06-20	CI
Mendus AB: Mendus announces Nomination Committee for the 2023 Annual General Meeting	22-11-10	GL
Mendus AB Announces Nomination Committee for 2023 Annual General Meeting	22-11-10	CI
Immunicum AB has Changed its Name to Mendus AB	22-06-23	CI
Immunicum AB Appoints Leopold Bertea as Chief Technology Officer	22-05-05	CI
Immunicum Announces Nomination Committee for the 2022 Annual General Meeting	21-11-03	AQ
Immunicum AB Appoints Nomination Committee for the 2022 Annual General Meeting	21-11-03	CI
Immunicum Appoints Interim CFO On Permanent Basis	21-10-26	MT
Immunicum AB Appoints Lotta Ferm as Chief Financial Officer	21-10-26	CI
Immunicum Appoints New Experts in Cancer Immunology to Scientific Advisory Board	21-09-30	CI
Immunicum AB Announces Board Changes	21-05-04	CI
Immunicum AB Announces Updated Executive Management Team After Business Combination	21-03-16	CI
Immunicum AB Appoints Erik Manting as Chief Executive Officer	21-03-16	CI
Immunicum AB Appoints Jeroen Rovers, M.D., Ph.D., to the Position of Chief Medical Officer	21-03-01	CI
Immunicum AB Approves Election of New Board Members	21-01-22	CI
Immunicum AB Announces Transitions in Board of Directors	21-01-21	CI
Immunicum : Changes to the Nomination Committee for Immunicum AB	20-12-30	AQ

No results for this search